FDA Approves Drug to Cut Cholesterol

May 6, 2013
The Food and Drug Administration approved a combination drug developed by Merck that lowers a patient’s cholesterol but has not been shown to reduce the risk of cardiovascular disease or death, the company said.
The drug pairs Merck’s Zetia, which lowers low-density lipoprotein (LDL or “bad cholesterol”) with the generic version of Lipitor, the best-selling statin made by Pfizer that lost its patent protection in 2011. Read the full story.